Ability of the plasma concentration ratio of triglyceride/high-density lipoprotein cholesterol to identify increased cardio-metabolic risk in an east Asian population

Diabetes Res Clin Pract. 2014 Jul;105(1):96-101. doi: 10.1016/j.diabres.2014.04.021. Epub 2014 Apr 28.

Abstract

Aim: The plasma concentration ratio of triglyceride (TG)/high-density lipoprotein cholesterol (HDL-C) has identified increased cardio-metabolic risk and outcome in European populations. The goal of this study was to see if this ratio would also have clinical utility in identifying cardio-metabolic risk in an East Asian population.

Methods: Measurements of various cardio-metabolic risk factors, including coronary calcium scores, were available on 12,166 apparently healthy Korean adults. Approximately 25% of men and women with the highest TG/HDL-C ratios were classified as being at high cardio-metabolic risk, and their risk factor profiles compared to the remainder of the population, as well as to individuals with the metabolic syndrome (MetS).

Results: High cardio-metabolic risk (upper 25%) was defined as a TG/HDL-C ratio ≥3.5 (men) or ≥2.0 (women), and all cardio-metabolic risk factors measured, including coronary calcium scores, were significantly more adverse when compared to individuals beneath these cut-points. Although cardio-metabolic risk profiles appeared reasonably comparable in subjects identified by either a high TG/HDL-C or a diagnosis of MetS, use of the TG/HDL-C increased the numbers at high risk.

Conclusion: Evidence that determination of the plasma TG/HDL-C concentration ratio provides a simple way to identify individual at increased cardio-metabolic risk has been extended to an East Asian population. The ability of an elevated TG/HDL-C ratio to accomplish this goal is comparable to that achieved using the more complicated MetS criteria.

Keywords: Cardio-metabolic disease; Coronary calcium; HDL-cholesterol; TG/HDL-C ratio; Triglyceride.

MeSH terms

  • Adult
  • Asia / epidemiology
  • Cardiovascular Diseases / blood*
  • Cardiovascular Diseases / epidemiology
  • Case-Control Studies
  • Cholesterol, HDL / blood*
  • Female
  • Humans
  • Male
  • Metabolic Syndrome / blood*
  • Metabolic Syndrome / epidemiology
  • Risk Assessment / methods*
  • Risk Factors
  • Triglycerides / blood*

Substances

  • Cholesterol, HDL
  • Triglycerides